Business Wire

Bioness Announces FDA 510K Clearance of StimRouter® System; a Novel, Implantable Neuromodulation Device Designed to Treat Chronic Peripheral Pain

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the StimRouter®, an implantable neuromodulation device designed to treat chronic ...
Business Wire

Bioness Announces First Commercial Procedure of StimRouter ™ Neuromodulation System

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness, Inc. announced today that the first commercial procedure of StimRouter ™ Neuromodulation System has been performed under the company’s FDA clearance to ...
Business Insider

Bioness Announces First United Kingdom Implant for StimRouter Neuromodulation System at Leeds Teaching Hospitals NHS Trust

VALENCIA, Calif., March 12, 2020 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically supported neuromodulation devices for the treatment of chronic pain of peripheral nerve ...
Business Insider

Bioness Announces Preliminary European Post-Approval Results of StimRouter® Neuromodulation System for the Treatment of Overactive Bladder at the 49th International Continence ...

StimRouter helping improve lives of patients in Europe and Australia beyond the management of chronic pain VALENCIA, California, Sept. 3, 2019 /PRNewswire/ -- Bioness, Inc., the leading provider of ...
Il Tempo

Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Overactive Bladder (OAB)

- VALENCIA, California, Feb. 18, 2019 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of chronic pain of peripheral nerve origin ...
PR Newswire

Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Fecal Incontinence

VALENCIA, California, Jan. 6, 2020 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of chronic pain of peripheral nerve origin, ...
Medindia

FDA Clears Bioness’ New Device ‘StimRouter’ to Treat Chronic Peripheral Pain

The U.S. Food and Drug Administration (FDA) has cleared StimRouter, an implantable neuromodulation device designed to treat chronic, intractable pain of peripheral nerve origin from. The device was ...
Medindia

Bioness StimRouter™ Neuromodulation System Clinical Data Presented At The 2017 North American Neuromodulation Society's Annual Meeting

VALENCIA, Calif., Jan. 20, 2017 /PRNewswire/ -- Bioness, Inc., the leading provider of state-of-the-art, clinically supported rehabilitation and pain management medical devices, is pleased to announce ...
Wausau Daily Herald

'I've got the body of an 80-year-old': She's 24, dealing with crippling genetic disorder

WAUSAU - She must be the only person in Wisconsin to ever suffer a crippling crocheting injury. "I told my doctor I thought I tore a ligament while crocheting (a shawl). ... It was an instant sharp ...
Finanznachrichten

Bioness StimRouter Neuromodulation System Receives CE Mark Approval for the Treatment of Overactive Bladder (OAB)

StimRouter now available in Europe beyond the management of chronic pain VALENCIA, California, Feb. 18, 2019 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically supported ...
Finanznachrichten

Bioness StimRouter Neuromodulation System Receives CE Mark Approval for the Treatment of Fecal Incontinence

StimRouter also available in Europe for managing chronic pain and overactive bladder VALENCIA, California, Jan. 6, 2020 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically ...